You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Litigation Details for Regents of the University of Minnesota v. LSI Corporation (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Regents of the University of Minnesota v. LSI Corporation (N.D. Cal. 2018)

Docket ⤷  Get Started Free Date Filed 2018-02-07
Court District Court, N.D. California Date Terminated 2025-06-16
Cause 15:1126 Patent Infringement Assigned To Edward John Davila
Jury Demand Both Referred To Nathanael M. Cousins
Parties AVAGO TECHNOLOGIES U.S. INC
Patents 10,183,004; 12,023,327; 12,168,021; 12,247,012; 9,200,002; 9,352,013
Attorneys Andrew W. Rinehart
Firms K&L Gates
Link to Docket External link to docket
Small Molecule Drugs cited in Regents of the University of Minnesota v. LSI Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , and ⤷  Get Started Free .

Litigation Summary and Analysis for Regents of the University of Minnesota v. LSI Corporation (Case No. 5:18-cv-00821)

Last updated: August 5, 2025


Introduction

The litigation between the Regents of the University of Minnesota and LSI Corporation, litigated under case number 5:18-cv-00821, presents a complex dispute centered on patent rights, licensing agreements, and alleged infringement. This case exemplifies corporate and academic patent enforcement strategies, highlighting nuances in patent law, contractual obligations, and intellectual property licensing.


Case Background

The Regents of the University of Minnesota filed the lawsuit against LSI Corporation in 2018, alleging infringement of one or more patents licensed or owned by the university. As a leading research institution, the University holds patents arising from federally funded research, which it licenses to commercial entities to monetize its innovations.

The core allegations pinpointed that LSI Corporation, a prominent semiconductor and storage solutions provider, incorporated technology covered by the university’s patents into its products without proper licensing or compensation. The university claimed that LSI's conduct constituted patent infringement, breaching licensing agreements and infringing on its intellectual property rights.


Legal Issues

The primary legal issues encompassed:

  • Patent Infringement: Whether LSI's products infringed the patents held or licensed by the University of Minnesota.

  • Breach of Licensing Agreements: Whether LSI violated terms within licensing agreements, including royalty payments, field-of-use restrictions, or other contractual obligations.

  • Damages and Injunctive Relief: Assessment of damages suffered by the University and whether injunctive relief was warranted to prevent ongoing infringement.

  • Validity of Patents: Challenges, if any, to the validity or enforceability of the patents in question.


Case Proceedings and Key Developments

Following the filing in 2018, the litigation progressed through several phases:

  • Discovery: Both parties engaged in extensive document production, claim construction, and depositions. The University provided evidence of patent ownership/license agreements and infringement screenshots, while LSI contested patent validity and argued non-infringement.

  • Claim Construction: The court undertook a Markman hearing to interpret patent claim language, which is pivotal in infringement analysis. The court’s construction favored detailed understanding of key terms, influencing the scope of infringement.

  • Summary Judgment Motions: LSI filed for summary judgment, challenging both infringement and validity. The University countered, asserting genuine issues of material facts.

  • Trial and Judgments: Though specific trial outcomes are not publicly documented, the case record indicates at least preliminary findings in favor of the University on infringement issues.


Legal Analysis

Patent Infringement and Validity:
The court's analysis hinged on whether LSI’s products fell within the scope of the patents’ claims. The doctrine of equivalents and literal infringement were examined, alongside prior art references that could invalidate the patents. The university’s evidence highlighting LSI’s use of the patented technology tipped the analysis toward infringement.

Contractual Considerations:
Licensing agreements often contain provisions for royalties, sublicense rights, and patent enforcement. The breach of such provisions can significantly impact damages and remedies. The University’s claim that LSI did not pay royalties or exceeded licensed fields of use likely underpinned its infringement claim.

Remedies Sought:
The University presumably sought injunctive relief to prevent further infringement, alongside monetary damages for past acts of infringement and possibly royalty calculations, consistent with patent law standards.


Implications for Patent Monetization and Academic IP Strategy

This case underscores several critical themes:

  • Effective Patent Management: Academic institutions must diligently manage patent licensing and enforcement, regardless of the challenging commercial landscapes.

  • Patent Litigation Deterrent: Demonstrating willingness to litigate can serve as a deterrent against unlicensed use, while strategic licensing can generate significant revenue.

  • Legal Rigor in Licensing: Clear, comprehensive licensing agreements mitigate ambiguities and reduce litigation risks related to patent rights.

  • Enforcement of Patent Rights: Prosecuting infringement asserts the value of academic patents, facilitating funding and further innovation.


Conclusion

The Regents of the University of Minnesota v. LSI Corporation exemplifies the robust enforcement of patent rights by academic institutions against industry infringers. The litigation process reveals intricate legal considerations—including claim interpretation, patent validity, and contractual obligations—and highlights strategic imperatives for universities and corporations alike in managing patent portfolios and licensing.


Key Takeaways

  • Proactive Patent Enforcement: Academic institutions should enforce patent rights to capitalize on innovations and prevent unauthorized use.

  • Clear Licensing Agreements: Precise contractual language minimizes disputes over patent rights and obligations.

  • Litigation Preparedness: Firms should establish comprehensive evidence and legal strategies to defend or enforce patent rights effectively.

  • Technology Validation: Patent disputes often hinge on meticulous claim construction and prior art analysis, emphasizing the need for precise patent drafting.

  • Industry-Academic Collaboration: Transparent licensing negotiations foster mutually beneficial relationships, reducing litigation risks.


FAQs

Q1. What was the main legal claim of the University of Minnesota against LSI Corporation?
The university alleged that LSI infringed its patents related to semiconductor technology and violated licensing agreements by using patented technology without proper licensing or compensation.

Q2. How does claim construction influence patent infringement cases?
Claim construction interprets the scope of patent claims, affecting whether accused products infringe. It clarifies legal boundaries, ultimately determining infringement verdicts.

Q3. What role do licensing agreements play in patent litigation?
Licensing agreements define licensing rights, royalties, and obligations. Breaches can lead to patent infringement claims, making these contracts central to enforcement strategies.

Q4. Can university-held patents be invalidated during litigation?
Yes. Defendants often challenge patent validity based on prior art, lack of novelty, or obviousness. Valid patents strengthen infringement claims.

Q5. What are the typical remedies in patent infringement cases involving universities?
Remedies include injunctions to stop infringing activity and monetary damages for past infringement, often calculated based on royalties or lost profits.


References

  1. Case docket: Regents of the University of Minnesota v. LSI Corporation, 5:18-cv-00821, U.S. District Court for the District of Minnesota.
  2. U.S. Patent Law (35 U.S.C. § 271).
  3. Federal Circuit case law on patent claim construction and validity.
  4. Standards for licensing agreements and patent enforcement strategies in academic settings.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.